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1. Introduction 
Recent data suggest different biological roles for 
type I and type II cyclic AMP-dependent protein 
kinases [ 11. The selective activation of type I protein 
kinase may represent a positive event in the process 
of activation of lymphocytes by a mitogenic signal, 
while the activation of type II enzyme may have an 
inhibitory effect on cell proliferation [2]. This 
hypothesis has been based on the assumption that in 
lymphocytes the dissociation of type I enzyme occurs 
at lower intracellular cyclic AMP concentration than 
that of type II enzyme. The differential activation of 
type I and type II kinases has been reported also in 
the liver of glucagon-treated rats [3 1. 
In the cytoplasmic extract of human tonsillar lym- 
phocytes we have found the type II regulatory sub- 
unit predominantly in the dissociated state, while 
type I enzyme was present mainly as holoenzyme or 
in a partially dissociation form [4]. This finding was 
unexpected in view of the above potential regulatory 
mechanism. To get more information about the 
behaviour of cyclic AMP-dependent protein kinase 
isoenzymes in lymphocytes we have investigated the 
relative distribution of the subunits in the cytoplas- 
mic and nuclear extracts of lymphocytes. 
2. Experimental 
HCl buffer (pH 7.5) and the protease inhibitor 
phenylmethylsulphonyl fluoride (0.002 M). The 
suspension was stirred for 15 min and centri- 
fuged at 1700 X g. The supernatant was centri- 
fuged again at 20 000 X g and the solution thus 
obtained was called the hypotonic extract. 
(b) Lymphocytes were suspended in a medium con- 
taining 0.15 M KC1/0.25 M sucrose/O.01 M 
MgC12/0.01 Tris-HCl buffer (PH 7.5)/0.002 M 
phenylmethylsulphonyl fluoride and were dis- 
rupted in a Potter-Elvehjem glass homogenizer. 
The suspension was centrifuged at 20 000 X g. 
(c) Lymphocytes were disrupted similarly as above 
in a medium containing 2.2 M sucrose/O.01 M 
MgClJ0.01 M Tris-HCl (pH 7.5)/0.002 M phen- 
ylmethylsulphonyl fluoride. 
The nuclear pellet of the cytoplasmic extract was 
suspended in 30 ml hypotonic KC1/MgClz/Tris-HCl 
buffer. The suspension was layered on top of 60 ml 
of the above buffer completed with 60% sucrose and 
centrifuged at 3500 X g for 30 min. The nuclei 
obtained were washed in 0.9% NaCl then resuspended 
in 8 ml 0.9% NaCl/O.OOS M potassium phosphate 
(pH 7.0)/0.002 M phenylmethylsulphonyl fluoride, 
homogenized with a teflon pestle and centrifuged at 
3500 X g. Homogenization was repeated with the pel- 
let resuspended in 8 ml of the same solution. The 
supernatants were combined and centrifuged at 
32 000 X g. This procedure yielded the physiological 
salt extract of nuclei. 
The isolation of lymphocytes from tonsils (l-2 h 
after tonsillectomy) was carried out as in [S]. Differ- 
ent methods were used to obtain cytoplasmic extracts: 
(a) Washed lymphocytes from 15 pairs of tonsils 
were suspended in 60 ml hypotonic solution con- 
taining 0.04 M KC1/0.02 M MgClz/O.Ol M Tris- 
The pellet remaining after the physiological salt 
extraction of nuclei was suspended in 8 ml solution 
containing 0.2 M EDTA (pH 6.5)/6.002 M phenyl- 
methylsulphonyl fluoride, then the suspension was 
homogenized and centrifuged as in the case of physio- 
logical salt extraction. This procedure was repeated 
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and the two supernatants were pooled and centri- 
fuged at 32 000 X g. The solution thus obtained was 
the EDTA extract of nuclei. In some experiments the 
physiological salt and EDTA extracts of nuclei were 
mixed to yield the ‘combined’ nuclear extract. 
The assay of protein kinase activity and of 
3H-labeled cyclic AMP binding was performed as in 
(41. The separation of cyclic AMP-dependent protein 
kinase isoenzymes was carried out on a DEAE- 
Sephacel column at pH 7.5 using potassium phos- 
phate gradient. All the extracts applied onto the 
DEAE-Sephacel were dialysed against 0.005 M potas- 
sium phosphate (PH 7.5). Dissociated catalytic sub- 
unit (M, - 40 000) was separated from the higher Mr 
enzyme forms by gel-chromatography on a Sephadex 
G-75 column. The identity of the separated catalytic 
subunit was controlled on the basis of inhibition by 
the heat-stable inhibitor protein [6]. 
3. Results and discussion 
The hypotonic extract of tonsillar lymphocytes 
contained mainly soluble cytoplasmic proteins. The 
DEAE-cellulose chromatography of this extract 
showed a large amount of type II regulatory subunit 
accompanied by negligible protein kinase activity and 
a significant amount of type I protein kinase in the 
holoenzyme or partially dissociated holoenzyme form 
(fig.1). The presence of type II regulatory subunit 
and the absence of type II holoenzyme were charac- 
teristic for the cytoplasmic extract even if the disrup- 
tion of cells occurred in the presence of 0.15 M KC1 
or in 2.2 M sucrose instead of the hypotonic medium. 
The hypotonic extraction and dialysis of the 
extract against 0.005 M potassium phosphate favours 
the association of type II regulatory and catalytic 
subunits to yield type II holoenzyme [7], but the 
association did not proceed even under these circum- 
stances. Proteolytic degradation of type II regulatory 
subunit may hinder the association but in these 
experiments this possibility can be excluded: as 
shown in [4], the presence of 0.002 M phenylmethyl- 
sulphonyl fluoride during the extraction procedure 
prevented the limited proteolysis of the type II regula- 
tory subunit. 
The dissociated catalytic subunit was completely 
absent from the cytoplasmic extract but it was pres- 
ent in the nuclear extract. This result was found with 
10 different preparations produced by disrupting the 
140 
cells either in the hypotonic medium or in the pres- 
ence of 0.15 M KCl. However when the disruption of 
cells was performed in the presence of 2 X 10m6 M 
cyclic AMP in the hypotonic medium then the cyto- 
plasmic holoenzyme I dissociated during the proce- 
dure and the dissociated catalytic subunit could be 
demonstrated in the cytoplasmic extract (fig.2). This 
control experiment showed that our method did not 
fraction number 
Fig.1. Isoenzymes of cyclic AMP-dependent protein kinase in 
the hypotonic cytoplasmic extract of human tonsillar lym- 
phocytes. The protein kinase activity of the fractions obtained 
by DEAE-Sephacel chromatography was measured in the 
absence (o-o) and in the presence (X-X) of 10m6 M cyclic 
AMP. Under the standard conditions of chromatography 
type I protein kinase from rabbit skeletal muscle eluted at 
the same position as type I enzyme (at 0.05 M phosphate) 
while type II kinase from bovine heart eluted at somewhat 
higher ionic strength (at -0.15 M phosphate) than type II 
kinase of lymphocytes. The protein kinase activity of lym- 
phocytes eluted at -0.15 M phosphate is identical with the 
cyclic nucleotide-independent histone kinase described in the 
cytoplasmic [S] and nuclear [ 111 extracts of human tonsillar 
lymphocytes. 
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cause the disappearance of the dissociated catalytic 
subunit from the cytoplasmic extract. 
The isoenzyme patterns of the physiological salt 
extract and the EDTA extract of nuclei were differ- 
ent (fig.3). In the physiological salt extract the type I 
B 
B 
fractron number 
E 
Fig.3. Isoenzymes of cyclic AMP-dependent protein kinase in 
the (A) physiological salt- and (B) EDTAextract of nuclei of 
tonsillar lymphocytes. The protein kinase activity of the frac- 
tions obtained by DEAE-Sephacel chromatography was mea- 
sured in the absence (o-o) and in the presence (X-X) of 
1O-6 M cyclic AMP. _LY!lL 
20 30 LO 
fraction 
was the dominating regulatory subunit but the sub- 
sequent EDTA-extraction of nuclei solubilized sig- 
nificant amounts of type II holoenzyme and disso- 
ciated catalytic subunit. It must be noted that in 2 
out of 7 experiments, type II regulatory subunit or 
holoenzyme were not detected in the EDTA extract, 
only a high amount of dissociated catalytic subunit 
was found. In the nuclear extract type II regulatory 
subunit was always accompanied by a protein kinase 
activity which was increased 3-8-times in the pres- 
ence of cyclic AMP. 
The cytoplasmic extract of human peripheral 
blood lymphocytes has been reported to contain pri- 
marily type I holoenzyme [8]. This observation is 
consistent with our results. In addition we found only 
the regulatory subunit of type II enzyme in a signiii- 
cant amount in the cytoplasmic extract. The appar- 
ently large excess of R,I subunit in the cytoplasm and 
number 
Fig.2. Demonstration of the dissociated catalytic subunit by 
Sephadex G-75 gel chromatography. The chromatographic 
profile of protein kinase activity in the (A) cytoplasmic and 
(B) ‘combined’ nuclear (cf. section 2) extracts prepared by 
disrupting the cells in hypotonic medium. The chromato- 
graphic profile of t,he (C) cytoplasmic and (D) ‘combined’ 
nuclear extracts prepared by disrupting the cells in the pres- 
ence of 0.15 M KCl. (E) Gel chromatography of a cytoplas- 
mic extract prepared: Lymphocytes were disrupted by stir- 
ring the cells in the hypotonic medium containing 2 x 10e6 M 
cyclic AMP. The suspension was further incubated at 0°C for 
60 min, then it was centrifuged as usual. All the extracts were 
concentrated 10 times in a Minicon B15 chamber before they 
were applied onto the column. The protein kinase activity of 
the fractions was measured with H2b histone as a substrate in 
the presence of 10m6 M cyclic AMP, in the absence (X -x) 
and in the presence (o-o) of the heat-stable inhibitor pro- 
tein [6]. 
141 
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the presence of a large amount of dissociated cata- 
lytic subunit in the nucleus suggest hat the subunits 
of type II enzyme were compartmentalized in differ- 
ent parts of the cell after activation of the enzyme. 
The translocation of the dissociated catalytic subunit 
from the cytoplasm into the nucleus is a well known 
phenomenon [9,10]. However, the possibility that 
the catalytic subunit of type II enzyme was trans- 
located into the nucleus while that of type I kinase 
remained in the cytoplasm can hardly be explained 
on the basis of the assumption that the type I 
enzyme is activated faster and reassociated more 
slowly than type II protein kinase. A rather unusual 
but conceivable explanation of our finding is that 
type II isoenzyme was originally in the nucleus and 
the activation of the enzyme was followed by the 
translocation of the regulatory subunit from the 
nucleus into the cytoplasm. This mechanism would 
be interesting in the view of a potential function of 
the regulatory subunit in addition to the inhibition of 
the catalytic subunit of the protein kinase. 
However, without regard to the original subcellular 
localisation of type II holoenzyme, our experiments 
strongly suggest hat in lymphocytes the primary site 
of action of the catalytic subunit of soluble cyclic 
AMP-dependent protein kinase is in the nucleus. 
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